YUM
43
-6
EA
60
-5
ECL
55
-2
HSY
31
-6
AEP
54
6
UAL
83
-2
TDC
67
-4
GE
61
-3
SBUX
37
-2
PBI
56
-2
CFG
74
2
CB
57
2
DVN
14
-6
CNP
54
10
PLD
45
-5
TEL
60
-8
UNH
57
-2
WYNN
36
-5
GS
72
4
HPE
44
-2
YUM
43
-6
EA
60
-5
ECL
55
-2
HSY
31
-6
AEP
54
6
UAL
83
-2
TDC
67
-4
GE
61
-3
SBUX
37
-2
PBI
56
-2
CFG
74
2
CB
57
2
DVN
14
-6
CNP
54
10
PLD
45
-5
TEL
60
-8
UNH
57
-2
WYNN
36
-5
GS
72
4
HPE
44
-2
Financhill
Back

BNY Mellon Emerging Markets Equity ETF Vs. Avidity Biosciences Industry Stock Comparison

Buy
52

BKEM
BNY Mellon Emerging Markets Equity ETF

Last Price:
59.34
Seasonality Move:
7.33%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Buy
52
BNY Mellon Emerging Markets Equity ETF (BKEM) is a Buy

Is BNY Mellon Emerging Markets Equity ETF a Buy, Sell or Hold?

  • The current BNY Mellon Emerging Markets Equity ETF [BKEM] share price is $59.37. The Score for BKEM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BKEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKEM Stock Price Chart

What is BNY Mellon Emerging Markets Equity ETF's stock price today?

  • The BNY Mellon Emerging Markets Equity ETF share price today is $59.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKEM is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

BKEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 34.28 Sell
Chaikin Money Flow: -1740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.75 - 63.13) Sell
Bollinger Bands (100): (59.08 - 63) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

BKEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.79 Sell
20-day SMA: 61.65 Sell
50-day SMA: 62.25 Sell
200-day SMA: 59.42 Sell
8-day EMA: 60.44 Sell
20-day EMA: 61.39 Sell
50-day EMA: 61.71 Sell
200-day EMA: 59.65 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

BNY Mellon Emerging Markets Equity ETF Earnings Growth & BKEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

BNY Mellon Emerging Markets Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):